- Home
- ULY vs TLPH Comparison
ULY vs TLPH Comparison
Compare ULY & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULY
- TLPH
- Stock Information
- Founded
- ULY 2013
- TLPH 2005
- Country
- ULY United States
- TLPH United States
- Employees
- ULY N/A
- TLPH N/A
- Industry
- ULY
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- ULY
- TLPH Health Care
- Exchange
- ULY Nasdaq
- TLPH Nasdaq
- Market Cap
- ULY 7.4M
- TLPH 10.6M
- IPO Year
- ULY N/A
- TLPH 2011
- Fundamental
- Price
- ULY $7.00
- TLPH $0.45
- Analyst Decision
- ULY Strong Buy
- TLPH Strong Buy
- Analyst Count
- ULY 2
- TLPH 1
- Target Price
- ULY $13.50
- TLPH $6.00
- AVG Volume (30 Days)
- ULY 1.3M
- TLPH 45.8K
- Earning Date
- ULY 08-11-2025
- TLPH 08-13-2025
- Dividend Yield
- ULY N/A
- TLPH N/A
- EPS Growth
- ULY N/A
- TLPH N/A
- EPS
- ULY N/A
- TLPH N/A
- Revenue
- ULY $134,085,000.00
- TLPH $27,000.00
- Revenue This Year
- ULY N/A
- TLPH N/A
- Revenue Next Year
- ULY $23.08
- TLPH $14,533.26
- P/E Ratio
- ULY N/A
- TLPH N/A
- Revenue Growth
- ULY N/A
- TLPH N/A
- 52 Week Low
- ULY $2.99
- TLPH $0.43
- 52 Week High
- ULY $22.50
- TLPH $1.19
- Technical
- Relative Strength Index (RSI)
- ULY 57.26
- TLPH 41.65
- Support Level
- ULY $5.40
- TLPH $0.45
- Resistance Level
- ULY $9.42
- TLPH $0.52
- Average True Range (ATR)
- ULY 0.88
- TLPH 0.03
- MACD
- ULY 0.36
- TLPH -0.00
- Stochastic Oscillator
- ULY 55.35
- TLPH 23.33
About ULY Urgent.ly Inc.
Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.